Breast Disorders
Gina S. Sucato
Growth of the breast is usually the first sign of puberty in girls, and it also occurs transiently during normal pubertal development in many boys. Most breast conditions that concern patients and their families are either variants of normal development or benign conditions. Routine breast examination of pediatric patients is important to allow reassurance about these conditions, as well as to detect the less common entities that require further evaluation and management.
BREAST EXAMINATION
Examination of the breast, including inspection and palpation, should occur during routine well-child examinations. During puberty, examination of both the male and female breast affords an opportunity to offer reassurance if indicated. When performing female breast examination, the presence of a chaperone is advisable. The clinician should ask the patient to lie supine and to take one arm out of her gown and place it behind her head. The entire breast should be inspected and then palpated using the flat finger pads of the middle three fingers to make dime-sized circles. A systematic approach, such as following the pattern of the spokes of a wheel or horizontal strips, will ensure thorough breast examination. The sexual maturity rating (Tanner stage) of each breast should be noted. It may put young women at ease to teach breast self-examination simultaneously. However, the primary purpose of teaching self-examination is to promote familiarity and acceptance of the breast, not for early detection of breast cancer, which is exceedingly rare in adolescence. The American Cancer Society now considers breast self-examination an optional component of breast cancer screening for women of all ages.
VARIATIONS OF NORMAL GROWTH AND DEVELOPMENT
Children of either sex can be born with polythelia (supernumerary nipples) or polymastia (extra breast tissue). These variations can be found anywhere from the axilla to the groin in up to 5% of healthy patients. Because polythelia may be associated with genitourinary abnormalities, a renal ultrasound study may be advisable for infants with this condition if it is accompanied by other congenital anomalies. More than half of both male and female newborns have palpable breast growth, sometimes with bilateral white nipple discharge. This benign condition results from maternal hormonal stimulation and resolves spontaneously, usually by 4 months of age. Although accessory breast tissue is usually asymptomatic, it may become engorged and painful in women during pregnancy or lactation.
Variations of growth and development in girls include breast hypoplasia, asymmetry, and hypertrophy. Amastia (total absence of the breast) is rare and usually unilateral. It is often secondary to chest wall anomalies such as absence of underlying muscle tissue, or Poland syndrome, which is characterized by aplasia of the pectoralis muscles, rib deformities, webbed fingers, and radial nerve palsy. Breast hypoplasia accompanied by signs of androgen excess in a female patient warrants further endocrinologic evaluation. Breast atrophy can be the result of malnutrition or weight loss, as seen with eating disorders or chronic disease.
Breast asymmetry is common, especially during early pubertal breast development. While the breasts are still growing, adolescents can be advised to use bra pads for the smaller breast. Although it frequently corrects by adulthood, visible asymmetry persists in approximately 25% of women, in which case surgical augmentation and reduction mammoplasty are options. Breast hypertrophy, or macromastia, typically begins in adolescence and is associated with obesity. Juvenile, or “virginal,” hypertrophy, with massive diffuse enlargement of one or both breasts during puberty, occurs rarely. Corrective surgery is preferably delayed until after breast development is complete.
COMMON CONDITIONS OF THE BREAST
Gynecomastia
Gynecomastia is enlargement of the male breast. During puberty, proliferation of breast tissue in both girls and boys is
stimulated by estrogen and antagonized by androgens. Early in puberty, adolescent boys may experience a transient imbalance between estrogen and androgen levels resulting in pubertal breast growth. This finding is common in early and middle adolescence and can be found in up to 64% of healthy 14-year-old boys. The majority of estrogen in males is produced outside the male testes, by peripheral aromatization of sex hormones in adipose tissue, muscle, and skin. Significant increase of aromatization, as occurs with obesity, can elevate levels of circulating estrogen and may exacerbate gynecomastia.
stimulated by estrogen and antagonized by androgens. Early in puberty, adolescent boys may experience a transient imbalance between estrogen and androgen levels resulting in pubertal breast growth. This finding is common in early and middle adolescence and can be found in up to 64% of healthy 14-year-old boys. The majority of estrogen in males is produced outside the male testes, by peripheral aromatization of sex hormones in adipose tissue, muscle, and skin. Significant increase of aromatization, as occurs with obesity, can elevate levels of circulating estrogen and may exacerbate gynecomastia.
TABLE 90.1. DRUGS ASSOCIATED WITH GYNECOMASTIA | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Pubertal gynecomastia frequently results in anxiety for boys who nonetheless may be reluctant to voice their concerns. Routine examination of the male breast during puberty offers the opportunity to reassure boys about this common, benign, and self-resolving condition. Only 4% of adolescents will have gynecomastia that persists into adulthood.
Evaluation of the patient with gynecomastia begins with a confidential history to determine use of prescription or other drugs that alter estrogen or androgen activity, some of which are listed in Table 90.1. The history of breast enlargement should include the patient’s age and Tanner stage at onset, the progression and duration of breast growth, and the presence of pain. Physical examination should focus on identifying signs of systemic disease, including liver or thyroid disease, assessing Tanner stage of the patient’s breasts, genitals, and pubic hair, and ruling out testicular mass or atrophy. Examination of the breast should distinguish gynecomastia from pseudogynecomastia. With the patient supine, place the thumb and forefinger at opposing margins of the breast and gently bring them together toward the nipple. Gynecomastia will be palpable as a disk of rubbery, freely mobile, occasionally tender, breast tissue directly under the areola. With adipose tissue, no discrete mass of breast tissue is present. Masses not consisting of breast tissue are usually not centered directly beneath the areola.